CRB Monitor Securities Database Updates
During the week of January 13 - 19, 2025, CRB Monitor’s research team made several updates to securities’ information and added source documents & relevant news articles to the CRB Monitor database.
Summary of the updates for the Week of January 13 - 19, 2025:
|
Tier |
Total # |
Active / Inactive / Pre-IPO |
Added |
Removed |
Net Change |
|
Tier 1A |
146 |
121 / 23 / 2 |
+0 | -0 | +0 |
|
Tier 1B |
703 |
552 / 149 / 2 |
+0 | -0 | +0 |
|
Tier 2 |
299 |
280 / 14 / 5 |
+0 | -0 | +0 |
|
Tier 3 |
461 |
433 / 27 / 1 |
+0 | -1 | -1 |
|
Total Issuances |
1,609 |
1,386 / 213 / 10 |
+0 | -1 | -1 |
|
Total Issuers (w/o Pre-IPOs) |
1,203 |
- |
+0 | -1 | -1 |
|
Total Issuers (w/ Pre-IPOs) |
1,213 |
- |
+0 | -1 | -1 |
Removed 1 Tier 3 Security:
- -1 = Discarded Business Record: ("TFF Pharmaceuticals, Inc.")
- Rationale = TFF Pharmaceuticals, Inc., based in United States, operates as an early-stage biopharmaceutical company. The company develops powder and molecule drugs for the treatment of chronic respiratory diseases and lung conditions. The company was previously involved in the cannabis industry through the development of dry powder formulations of cannabinoid-based vaccines, primarily including cannabidiol (CBD). However, the company's security has been revoked/delisted and it no longer trades (previously traded on NASDAQ). As a result, the company is now private. This is a business without any connection to (1) a cannabis license/"plant-touching" operation, (2) a Tier 1 CRB, and/or (3) a publicly-traded CRB. Therefore, this business no longer qualifies for inclusion.
All newly-identified CRBs during the week:
|
Company Name |
Tier |
Pure-Play | Sector |
Description |
|
N/A |
N/A | N/A | N/A |
N/A |